Serveur d'exploration SRAS - Curation (Ncbi)

Index « Keywords » - entrée « Ribavirin (pharmacology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Ribavirin (metabolism) < Ribavirin (pharmacology) < Ribavirin (therapeutic use)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000063 (2003) Dennis NormileInfectious diseases. Battling SARS on the frontlines.
000483 (2003) Xiang Xu [République populaire de Chine] ; Yunqing Liu ; Susan Weiss ; Eddy Arnold ; Stefan G. Sarafianos ; Jianping DingMolecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design.
000698 (2004) Ute Ströher [Canada] ; Antonino Dicaro [Italie] ; Yan Li [Canada] ; James E. Strong [Canada] ; Fred Aoki [Canada] ; Frank Plummer [Canada] ; Steven M. Jones [Canada] ; Heinz Feldmann [Canada]Severe Acute Respiratory Syndrome-Related Coronavirus Is Inhibited by Interferon-α
000975 (2004) F. Chen [Hong Kong] ; K. H Chan [Hong Kong] ; Y. Jiang [Hong Kong] ; R. Y. T Kao [Hong Kong] ; H. T Lu [Hong Kong] ; K. W Fan [Hong Kong] ; V. C. C Cheng [Hong Kong] ; W. H. W Tsui [Hong Kong] ; I. F. N Hung [Hong Kong] ; T. S. W Lee [Hong Kong] ; Y. Guan [Hong Kong] ; J. S. M Peiris [Hong Kong] ; K. Y Yuen [Hong Kong]In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
000D22 (2005) Jindrich Cinatl [Allemagne] ; Martin Michaelis ; Birgit Morgenstern ; Hans Wilhelm DoerrHigh-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cells.
000F68 (2005) Masayuki Saijo [Japon] ; Shigeru Morikawa ; Shuetsu Fukushi ; Tetsuya Mizutani ; Hideki Hasegawa ; Noriyo Nagata ; Naoko Iwata ; Ichiro KuraneInhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus.
001461 (2006) Dale L. Barnard [États-Unis] ; Craig W. Day ; Kevin Bailey ; Matthew Heiner ; Robert Montgomery ; Larry Lauridsen ; Scott Winslow ; Justin Hoopes ; Joseph K-K Li ; Jongdae Lee ; Dennis A. Carson ; Howard B. Cottam ; Robert W. SidwellEnhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
001516 (2006) Shiro Shigeta [Japon] ; Shuichi Mori ; Toshihiro Yamase ; Norio Yamamoto ; Naoki YamamotoAnti-RNA virus activity of polyoxometalates.
001873 (2006) Carla Amici [Italie] ; Antonino Di Caro ; Alessandra Ciucci ; Lucia Chiappa ; Concetta Castilletti ; Vito Martella ; Nicola Decaro ; Canio Buonavoglia ; Maria R. Capobianchi ; M Gabriella SantoroIndomethacin has a potent antiviral activity against SARS coronavirus.
001A08 (2007) Dessmon Y H. Tai [Singapour]Pharmacologic treatment of SARS: current knowledge and recommendations.
001D38 (????) R A Khamitov ; S Ia Loginova ; V N Shchukina ; S V Borisevich ; V A Maksimov ; A M Shuster[Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures].
002501 (2011) V N Shchukina ; S Ia Loginova ; S V Borisevich ; V P Bondarev[Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome].
002620 (2013) Meng Wu [République populaire de Chine] ; Ziwen Wang ; Chuisong Meng ; Kailiang Wang ; Yanna Hu ; Lizhong Wang ; Qingmin WangDiscovery and SARs of trans-3-aryl acrylic acids and their analogs as novel anti-tobacco mosaic virus (TMV) agents.
002D95 (2017) Lu Yu [République populaire de Chine] ; Xiuhai Gan [République populaire de Chine] ; Dagui Zhou [République populaire de Chine] ; Fangcheng He [République populaire de Chine] ; Song Zeng [République populaire de Chine] ; Deyu Hu [République populaire de Chine]Synthesis and Antiviral Activity of Novel 1,4-Pentadien-3-one Derivatives Containing a 1,3,4-Thiadiazole Moiety.
002E64 (2017) Kevin W. Graepel [États-Unis] ; Xiaotao Lu [États-Unis] ; James Brett Case [États-Unis] ; Nicole R. Sexton [États-Unis] ; Everett Clinton Smith [États-Unis] ; Mark R. Denison [États-Unis]Proofreading-Deficient Coronaviruses Adapt for Increased Fitness over Long-Term Passage without Reversion of Exoribonuclease-Inactivating Mutations.
002E91 (2017) François Ferron [France] ; Lorenzo Subissi [France] ; Ana Theresa Silveira De Morais [France] ; Nhung Thi Tuyet Le [France] ; Marion Sevajol [France] ; Laure Gluais [France] ; Etienne Decroly [France] ; Clemens Vonrhein ; Gérard Bricogne ; Bruno Canard [France] ; Isabelle Imbert [France]Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Ribavirin (pharmacology)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Ribavirin (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Ribavirin (pharmacology)
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021